Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The Class Period for the Semler Scientific securities is from March 10, 2021, to April 15, 2025 [1]. - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these omissions led to investor damages when the true details became public [5].

Core Points - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, is investigating Semler Scientific, Inc. regarding its sale to Strive, Inc. [1] - Upon completion of the proposed transaction, Semler shareholders will receive 21.05 Class A common shares of Strive for each share of Semler [1] - The firm has a successful track record and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] Company Overview - Monteverde & Associates PC is headquartered in the Empire State Building, New York City, and specializes in class action securities litigation [2] - The firm has recovered millions for shareholders and has experience in trial and appellate courts, including the U.S. Supreme Court [2] Contact Information - For concerns or additional information, shareholders can contact Juan Monteverde via email or telephone [3]

, /PRNewswire/ -- Why:Â Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the "Class Period"), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased Semler Scientific securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or co ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options If you suffered losses in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi ...

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...

, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/semler-scientific-inc-loss-submission-form/?id=170626&from=4 CLASS PERIOD: March 10, 2021 to April 1 ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. due to allegations of violations of federal securities laws, particularly concerning undisclosed investigations by the DOJ [4][6]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Semler Scientific to contact them to discuss their legal options [1][9]. - A federal securities class action has been filed against Semler Scientific, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [4][8]. - The complaint alleges that Semler Scientific and its executives made false or misleading statements regarding a material investigation by the DOJ related to the False Claims Act [6][7]. Group 2: Company Performance and Stock Impact - Following the filing of its 2024 annual report on February 28, 2025, which disclosed initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9% on the next trading day [7]. - The annual report indicated that the company does not believe the amount of loss from potential DOJ actions can be reasonably estimated [7]. Group 3: Investor Participation - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member, with their ability to share in any recovery unaffected by this decision [8]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Semler Scientific's conduct [9].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified class period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The class period for the Semler Scientific securities class action is from March 10, 2021, to April 15, 2025 [1]. - Investors who purchased Semler Scientific securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by October 28, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. - The lawsuit claims that these misleading statements resulted in investor damages when the true details became public [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][3]. Group 1: Class Action Details - Investors who bought Semler Scientific securities between March 10, 2021, and April 15, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file a motion by October 28, 2025 [3]. - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [4]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [4].

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act, which has led to investor losses during the class period from March 10, 2021, to April 15, 2025 [3][7]. Allegation Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the DOJ into potential violations of the False Claims Act while discussing such violations in hypothetical terms [3]. - As a result of these omissions, the public statements made by the defendants were materially false and misleading throughout the relevant period [3]. Next Steps for Investors - Investors who purchased or acquired Semler shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information regarding their rights and potential claims [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5].